Contact Us

Biogen Alzheimer’s drug could get Medicare coverage in 2025 if approved, says Dr. Scott Gottlieb

Thought Leader: Scott Gottlieb
January 6, 2023
Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins ‘Squawk Box’ to discuss if Biogen’s drug is tackling the root cause of Alzheimer’s, what scientists are learning from Biogen’s Alzheimer’s treatment and more.


Subscribe to the WWSG newsletter.

Check Availability

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Speaker List
Share My List